<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Rxsight, Inc. — News on 6ix</title>
<link>https://6ix.com/company/rxsight-inc</link>
<description>Latest news and press releases for Rxsight, Inc. on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Wed, 06 May 2026 20:05:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/rxsight-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835bb6978dffbe2df11651b.webp</url>
<title>Rxsight, Inc.</title>
<link>https://6ix.com/company/rxsight-inc</link>
</image>
<item>
<title>RxSight, Inc. Reports First Quarter 2026 Results and Reiterates Full-Year Sales Outlook</title>
<link>https://6ix.com/company/rxsight-inc/news/rxsight-inc-reports-first-quarter-2026-results-and-reiterates-full-year-sales-outlook</link>
<guid isPermaLink="true">https://6ix.com/company/rxsight-inc/news/rxsight-inc-reports-first-quarter-2026-results-and-reiterates-full-year-sales-outlook</guid>
<pubDate>Wed, 06 May 2026 20:05:00 GMT</pubDate>
<description>ALISO VIEJO, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today reported financial results for the quarter ended March 31, 2026. Strategic Highlights and Recent Developments Q1 sales of $30.9 million driven by 27,472 Light Adjustable Lens (LAL) units20 Light Delivery Devices (LDDs) sold in Q1, expanding the installed base to 1,154 unitsRobust clinical data presented at the recent American Society of Cataract and Refractive Surgery (ASCRS) annual meeting highlighting the</description>
</item>
<item>
<title>RxSight, Inc. to Report First Quarter 2026 Financial Results on May 6</title>
<link>https://6ix.com/company/rxsight-inc/news/rxsight-inc-to-report-first-quarter-2026-financial-results-on-may-6</link>
<guid isPermaLink="true">https://6ix.com/company/rxsight-inc/news/rxsight-inc-to-report-first-quarter-2026-financial-results-on-may-6</guid>
<pubDate>Wed, 22 Apr 2026 20:10:00 GMT</pubDate>
<description>ALISO VIEJO, Calif., April 22, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., today announced that it will report financial results for the first quarter after the market close on Wednesday, May 6, 2026. The company’s management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. To participate in the conference call, please dial (800) 715-9871 or (646) 307-1963, and enter the conference code: 2630350. The call will also be br</description>
</item>
<item>
<title>RxSight Highlights 300,000 Light Adjustable Lens Implant Milestone and Strong Scientific Presence at ASCRS 2026</title>
<link>https://6ix.com/company/rxsight-inc/news/rxsight-highlights-300000-light-adjustable-lens-implant-milestone-and-strong-scientific-presence-at-ascrs-2026</link>
<guid isPermaLink="true">https://6ix.com/company/rxsight-inc/news/rxsight-highlights-300000-light-adjustable-lens-implant-milestone-and-strong-scientific-presence-at-ascrs-2026</guid>
<pubDate>Wed, 08 Apr 2026 20:05:00 GMT</pubDate>
<description>WASHINGTON, April 08, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today announced, in advance of the 2026 American Society of Cataract and Refractive Surgery (ASCRS) annual meeting, that over 300,000 Light Adjustable Lens® (LAL®) implants have been performed since launch, marking a significant milestone in the company’s pursuit to make customized vision correction widely available to patients. The RxSight® Light Adjustable Lens system is the first and only intraocular lens (IOL) techno</description>
</item>
<item>
<title>RxSight, Inc. to Participate in the 25th Annual Needham Virtual Healthcare Conference</title>
<link>https://6ix.com/company/rxsight-inc/news/rxsight-inc-to-participate-in-the-25th-annual-needham-virtual-healthcare-conference</link>
<guid isPermaLink="true">https://6ix.com/company/rxsight-inc/news/rxsight-inc-to-participate-in-the-25th-annual-needham-virtual-healthcare-conference</guid>
<pubDate>Thu, 02 Apr 2026 20:10:00 GMT</pubDate>
<description>ALISO VIEJO, Calif., April 02, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., today announced plans to participate in the upcoming 25th Annual Needham Virtual Healthcare Conference. Management is scheduled to participate in a fireside chat on Thursday, April 16, 2026, at 8:00 a.m. Pacific Time. A live and archived webcast of the presentation will be available on the company’s investor relations website at https://investors.rxsight.com/. About RxSight, Inc. RxSight, Inc. is an ophthalmic</description>
</item>
<item>
<title>RXSight, Inc. Reports Fourth Quarter and 2025 Results; Issues 2026 Guidance</title>
<link>https://6ix.com/company/rxsight-inc/news/rxsight-inc-reports-fourth-quarter-and-2025-results-issues-2026-guidance</link>
<guid isPermaLink="true">https://6ix.com/company/rxsight-inc/news/rxsight-inc-reports-fourth-quarter-and-2025-results-issues-2026-guidance</guid>
<pubDate>Wed, 25 Feb 2026 21:05:00 GMT</pubDate>
<description>ALISO VIEJO, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today reported financial results for the quarter and full year ended December 31, 2025. Strategic Highlights and Recent Developments 2025 Light Adjustable Lens (LAL® and LAL+®) unit sales increased 12% to 109,615Over 300,000 RxSight LAL procedures performed since launch, reinforcing the benefits of post-operative adjustability in clinical practiceLight Delivery Devices (LDD™) installed base expanded to 1,134, pro</description>
</item>
<item>
<title>RxSight, Inc. To Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026</title>
<link>https://6ix.com/company/rxsight-inc/news/rxsight-inc-report-fourth-quarter-211000485</link>
<guid isPermaLink="true">https://6ix.com/company/rxsight-inc/news/rxsight-inc-report-fourth-quarter-211000485</guid>
<pubDate>Wed, 11 Feb 2026 21:10:00 GMT</pubDate>
<description>ALISO VIEJO, Calif., Feb. 11, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, will report financial results for the fourth quarter and full year 2025 after the market close on Wednesday, February 25, 2026. The company’s management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. To participate in the conference c</description>
</item>
<item>
<title>RxSight, Inc. Announces Preliminary Q4 and 2025 Financial Results; New Chief Financial Officer</title>
<link>https://6ix.com/company/rxsight-inc/news/rxsight-inc-announces-preliminary-q4-143000689</link>
<guid isPermaLink="true">https://6ix.com/company/rxsight-inc/news/rxsight-inc-announces-preliminary-q4-143000689</guid>
<pubDate>Sun, 11 Jan 2026 14:30:00 GMT</pubDate>
<description>ALISO VIEJO, Calif., Jan. 11, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced certain preliminary unaudited financial and operational results for the fourth quarter and full-year 2025. In addition, the company provided an update on the previously announced Chief Financial Officer transition. Preliminary Unaudited Fourth Quarter and Full-year</description>
</item>
<item>
<title>RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference</title>
<link>https://6ix.com/company/rxsight-inc/news/rxsight-inc-present-j-p-210500517</link>
<guid isPermaLink="true">https://6ix.com/company/rxsight-inc/news/rxsight-inc-present-j-p-210500517</guid>
<pubDate>Fri, 02 Jan 2026 21:05:00 GMT</pubDate>
<description>ALISO VIEJO, Calif., Jan. 02, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming J.P. Morgan Healthcare Conference. RxSight’s management is scheduled to present on Tuesday, January 13, 2026, at 3:45 p.m. Pacific Time / 6:45 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation at: ht</description>
</item>
<item>
<title>RxSight, Inc. Announces Chief Financial Officer Transition</title>
<link>https://6ix.com/company/rxsight-inc/news/rxsight-inc-announces-chief-financial-221500349</link>
<guid isPermaLink="true">https://6ix.com/company/rxsight-inc/news/rxsight-inc-announces-chief-financial-221500349</guid>
<pubDate>Mon, 22 Dec 2025 22:15:00 GMT</pubDate>
<description>ALISO VIEJO, Calif., Dec. 22, 2025 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced that Shelley Thunen, the Company’s Chief Financial Officer, is transitioning from her role. Ms. Thunen will remain with the Company until the sooner of the appointment of her successor or January 31, 2026. Ms. Thunen has agreed to support the Company as a consultant subsequent to th</description>
</item>
<item>
<title>RxSight, Inc. to Present at the Piper Sandler Healthcare Conference</title>
<link>https://6ix.com/company/rxsight-inc/news/rxsight-inc-present-piper-sandler-210500135</link>
<guid isPermaLink="true">https://6ix.com/company/rxsight-inc/news/rxsight-inc-present-piper-sandler-210500135</guid>
<pubDate>Thu, 20 Nov 2025 21:05:00 GMT</pubDate>
<description>ALISO VIEJO, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) – November 20, 2025 – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Piper Sandler 37th Annual Healthcare Conference in New York City. RxSight’s management is scheduled to present on Wednesday, December 3, 2025, at 12:00 p.m. Eastern Time. A live and archived webcast of the pre</description>
</item>
<item>
<title>RxSight, Inc. Reports Third Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/rxsight-inc/news/rxsight-inc-reports-third-quarter-210500320</link>
<guid isPermaLink="true">https://6ix.com/company/rxsight-inc/news/rxsight-inc-reports-third-quarter-210500320</guid>
<pubDate>Wed, 05 Nov 2025 21:05:00 GMT</pubDate>
<description>ALISO VIEJO, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today reported financial results for the three months ended September 30, 2025. Key Financial Highlights Reported third quarter 2025 revenue of $30.3 million, representing a decrease of 14% compared to the third quarter of 2024, reflecting: The sale of 26,045 Light Adjustable Lense</description>
</item>
<item>
<title>RxSight, Inc. to Report Third Quarter 2025 Financial Results on November 5, 2025</title>
<link>https://6ix.com/company/rxsight-inc/news/rxsight-inc-report-third-quarter-200500888</link>
<guid isPermaLink="true">https://6ix.com/company/rxsight-inc/news/rxsight-inc-report-third-quarter-200500888</guid>
<pubDate>Wed, 22 Oct 2025 20:05:00 GMT</pubDate>
<description>ALISO VIEJO, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, will report financial results for the third quarter of 2025 after the market close on Wednesday, November 5, 2025. The company’s management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. To participate in the conferen</description>
</item>
<item>
<title>RxSight, Inc. to Feature Live Learning Sessions at American Academy of Ophthalmology 2025 Annual Meeting</title>
<link>https://6ix.com/company/rxsight-inc/news/rxsight-inc-feature-live-learning-200500693</link>
<guid isPermaLink="true">https://6ix.com/company/rxsight-inc/news/rxsight-inc-feature-live-learning-200500693</guid>
<pubDate>Thu, 16 Oct 2025 20:05:00 GMT</pubDate>
<description>ALISO VIEJO, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced it will be featured in multiple Live Learning Sessions at Booth #2931 during the American Academy of Ophthalmology Annual Meeting (AAO 2025), taking place October 18–20 at the Orange County Convention Center in Orlando, Fla. This year’s Live Learning Sessions showcase</description>
</item>
<item>
<title>RxSight, Inc. to Present at the Morgan Stanley Healthcare Conference</title>
<link>https://6ix.com/company/rxsight-inc/news/rxsight-inc-present-morgan-stanley-200500199</link>
<guid isPermaLink="true">https://6ix.com/company/rxsight-inc/news/rxsight-inc-present-morgan-stanley-200500199</guid>
<pubDate>Mon, 25 Aug 2025 20:05:00 GMT</pubDate>
<description>ALISO VIEJO, Calif., Aug. 25, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Morgan Stanley Healthcare Conference in New York City. RxSight’s management is scheduled to present on Monday, September 8, 2025, at 7:45 a.m. Pacific Time / 10:45 a.m. Eastern Time. A live and archived webcast of the presentation</description>
</item>
<item>
<title>RxSight, Inc. to Present at the Wells Fargo Healthcare Conference</title>
<link>https://6ix.com/company/rxsight-inc/news/rxsight-inc-present-wells-fargo-200500034</link>
<guid isPermaLink="true">https://6ix.com/company/rxsight-inc/news/rxsight-inc-present-wells-fargo-200500034</guid>
<pubDate>Thu, 14 Aug 2025 20:05:00 GMT</pubDate>
<description>ALISO VIEJO, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Wells Fargo Healthcare Conference in Boston. RxSight’s management is scheduled to present on Thursday, September 4, 2025, at 7:15 a.m. Pacific Time / 10:15 a.m. Eastern Time. A live and archived webcast of the presentation will be available at: h</description>
</item>
<item>
<title>RxSight, Inc. Reports Second Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/rxsight-inc/news/rxsight-inc-reports-second-quarter-200500822</link>
<guid isPermaLink="true">https://6ix.com/company/rxsight-inc/news/rxsight-inc-reports-second-quarter-200500822</guid>
<pubDate>Thu, 07 Aug 2025 20:05:00 GMT</pubDate>
<description>ALISO VIEJO, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today reported financial results for the three months ended June 30, 2025. Key Company Highlights Reported second quarter 2025 revenue of $33.6 million, representing a decrease of 4% compared to the second quarter of 2024, reflecting: The sale of 27,380 Light Adjustable Lenses (LAL</description>
</item>
<item>
<title>RxSight, Inc. Appoints Raymond W. Cohen to Its Board of Directors</title>
<link>https://6ix.com/company/rxsight-inc/news/rxsight-inc-appoints-raymond-w-120500624</link>
<guid isPermaLink="true">https://6ix.com/company/rxsight-inc/news/rxsight-inc-appoints-raymond-w-120500624</guid>
<pubDate>Mon, 04 Aug 2025 12:05:00 GMT</pubDate>
<description>ALISO VIEJO, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced the appointment of Raymond W. Cohen to its Board of Directors. “We are thrilled to welcome Raymond W. Cohen to the RxSight Board of Directors,” said J. Andy Corley, Chairman of the Board at RxSight. “Ray’s extensive track record in leading and scaling medical techno</description>
</item>
<item>
<title>RxSight, Inc. to Report Second Quarter 2025 Financial Results on August 7, 2025</title>
<link>https://6ix.com/company/rxsight-inc/news/rxsight-inc-report-second-quarter-200500926</link>
<guid isPermaLink="true">https://6ix.com/company/rxsight-inc/news/rxsight-inc-report-second-quarter-200500926</guid>
<pubDate>Thu, 24 Jul 2025 20:05:00 GMT</pubDate>
<description>ALISO VIEJO, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, will report financial results for the second quarter of 2025 after the market close on Thursday, August 7, 2025. The company’s management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. To participate in the conference</description>
</item>
<item>
<title>RxSight, Inc. Announces Preliminary Second Quarter 2025 Revenue and Revised 2025 Guidance</title>
<link>https://6ix.com/company/rxsight-inc/news/rxsight-inc-announces-preliminary-second-200500978</link>
<guid isPermaLink="true">https://6ix.com/company/rxsight-inc/news/rxsight-inc-announces-preliminary-second-200500978</guid>
<pubDate>Tue, 08 Jul 2025 20:05:00 GMT</pubDate>
<description>ALISO VIEJO, Calif., July 08, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced select preliminary financial results for the second quarter 2025 and revised full-year 2025 guidance. The Company will host a conference call on Tuesday, July 8, 2025, at 5:00 p.m. Eastern Time. Preliminary Second Quarter 2025 Results Preliminary second quarter 2025</description>
</item>
<item>
<title>RxSight, Inc. to Participate in the Stifel 2025 Virtual Ophthalmology Forum</title>
<link>https://6ix.com/company/rxsight-inc/news/rxsight-inc-participate-stifel-2025-201000208</link>
<guid isPermaLink="true">https://6ix.com/company/rxsight-inc/news/rxsight-inc-participate-stifel-2025-201000208</guid>
<pubDate>Tue, 20 May 2025 20:10:00 GMT</pubDate>
<description>ALISO VIEJO, Calif., May 20, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Stifel Virtual Ophthalmology Forum. RxSight’s management is scheduled to participate in a fireside chat on Tuesday, May 27, 2025, at 10:30 a.m. Pacific Time / 1:30 p.m. Eastern Time. A live and archived webcast of the presentatio</description>
</item>
</channel>
</rss>